Deleterious heteroplasmic mitochondrial mutations increase risk of overall and cancer-specific mortality
Stephanie L Battle, Yun Soo Hong, Wen Shi, Daniela Puiu, Vamsee Pillalamarri, Nathan Pankratz, Nicole J Lake, Monkol Lek, View ORCID ProfileEliseo Guallar, Dan E Arking
doi: https://doi.org/10.1101/2022.09.20.22280151
Stephanie L Battle
1McKusick-Nathans Institute, Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Yun Soo Hong
1McKusick-Nathans Institute, Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Wen Shi
1McKusick-Nathans Institute, Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Daniela Puiu
2Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA
Vamsee Pillalamarri
1McKusick-Nathans Institute, Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Nathan Pankratz
3Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA
Nicole J Lake
4Department of Genetics, Yale School of Medicine, New Haven, CT, USA
5Murdoch Children’s Research Institute, Royal Children’s Hospital, Melbourne, Victoria, Australia
Monkol Lek
4Department of Genetics, Yale School of Medicine, New Haven, CT, USA
Eliseo Guallar
6Departments of Epidemiology and Medicine, and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, 21205, USA
Dan E Arking
1McKusick-Nathans Institute, Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Data Availability
All data in the present study were obtained directly from the UK Biobank.
Posted September 20, 2022.
Deleterious heteroplasmic mitochondrial mutations increase risk of overall and cancer-specific mortality
Stephanie L Battle, Yun Soo Hong, Wen Shi, Daniela Puiu, Vamsee Pillalamarri, Nathan Pankratz, Nicole J Lake, Monkol Lek, Eliseo Guallar, Dan E Arking
medRxiv 2022.09.20.22280151; doi: https://doi.org/10.1101/2022.09.20.22280151
Deleterious heteroplasmic mitochondrial mutations increase risk of overall and cancer-specific mortality
Stephanie L Battle, Yun Soo Hong, Wen Shi, Daniela Puiu, Vamsee Pillalamarri, Nathan Pankratz, Nicole J Lake, Monkol Lek, Eliseo Guallar, Dan E Arking
medRxiv 2022.09.20.22280151; doi: https://doi.org/10.1101/2022.09.20.22280151
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)